Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2008
10/07/2008CA2384572C Pesticidal macrolides
10/07/2008CA2375714C Delayed total release two pulse gastrointestinal drug delivery system
10/07/2008CA2369753C (s)-enantiomer enriched fipronil composition
10/07/2008CA2366841C Tolperisone-containing pharmaceutical preparation for oral administration
10/07/2008CA2362831C Thioamide derivatives
10/07/2008CA2362582C Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases
10/07/2008CA2359872C Gels formed by the interaction of poly(aldehyde) with various substances
10/07/2008CA2359494C Polymer compositions for intraluminal stent
10/07/2008CA2353205C Agent for treating parkinson's disease comprising astrocyte function-improving agent as active ingredient
10/07/2008CA2350815C Stable amorphous amifostine compositions and methods for the preparation and use of same
10/07/2008CA2335300C Macrocyclic analogs and methods and their use and preparation
10/07/2008CA2331461C Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis
10/07/2008CA2330256C Treatment of inflammatory bowel disease
10/07/2008CA2321523C Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants
10/07/2008CA2305926C Stable crystalline salts of 5-methyltetrahydrofolic acid
10/07/2008CA2286644C Drug delivery via therapeutic hydrogels
10/07/2008CA2280715C Oral preparation for the prophylactic and therapeutic treatment of helicobacter sp.infection
10/07/2008CA2261263C Use of sex steroid function modulators to treat wounds and fibrotic disorders
10/07/2008CA2259532C Transdermal drug delivery matrix for coadministering estradiol and another steroid
10/07/2008CA2251353C Transdermal delivery device for azapirone compounds
10/07/2008CA2242114C Nutritional supplement for the treatment and prevention of excessive intestinal permeability
10/07/2008CA2237306C Administration media for analgesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs
10/07/2008CA2225022C New polymorphous form of doxazosine mesylate (form iii)
10/07/2008CA2209426C Human pak65
10/07/2008CA2181909C Aromatic 2-amino-imidazole derivatives as alpha-2a adrenoceptor agonists
10/07/2008CA2179955C Kappa-opiate agonists for inflammatory bowel disorders
10/04/2008WO2008127226A2 P13 kinase antagonists
10/04/2008CA2639579A1 Pi3 kinase antagonists
10/02/2008WO2008119070A1 Methods of treatment using sirt modulators and compositions containing sirt1 modulators
10/02/2008WO2008119057A2 The use of pde7 inhibitors for the treatment of movement disorders
10/02/2008WO2008119032A1 Compositions and methods for protecting cells from toxic exposures
10/02/2008WO2008119017A1 11beta-hsd1 active compounds
10/02/2008WO2008119005A1 3,4-dehydro-proline-containing inhibitors of dipeptidylpeptidase iv
10/02/2008WO2008118948A1 Methods and compositions of derivatives of probucol for the treatment of diabetes
10/02/2008WO2008118946A1 Methods and compositions using certain phenolic derivatives for the treatment of diabetes
10/02/2008WO2008118935A1 Compounds and processes for preparing substituted aminomethyl-2,3,8,9-tetrahydro-7h-1,4-dioxino[2,3-e]indol-8-ones
10/02/2008WO2008118883A1 Administering antisense oligonucleotides complementary to human apolipoprotein b
10/02/2008WO2008118881A1 Method and packages to enhance safety when using imiquimod to treat children diagnosed with skin disorders
10/02/2008WO2008118879A2 Antiviral compositions comprising 2 compounds
10/02/2008WO2008118862A1 Carotenoid analogs and derivatives for the prevention of platelet aggregation
10/02/2008WO2008118852A1 Method for treating and preventing arthritis
10/02/2008WO2008118849A2 Hiv-1 protease inhibitors
10/02/2008WO2008118848A1 N-substituted peptidomimetic inhibitors of dipeptidylpeptidase iv
10/02/2008WO2008118847A1 Composition and method for treating cancer
10/02/2008WO2008118844A1 Methods involving aldose reductase inhibitors
10/02/2008WO2008118823A2 Compositions and methods for inhibition of the jak pathway
10/02/2008WO2008118802A1 Therapeutic compounds
10/02/2008WO2008118790A1 Dihydroindazole compounds useful in treating iron disorders
10/02/2008WO2008118765A1 Methods and packages to enhance safety when using imiquimod to treat children diagnosed with skin disorders
10/02/2008WO2008118763A1 Methods and packages to enhance safety when using imiquimod to treat children diagnosed with skin disorders
10/02/2008WO2008118762A1 Methods and packages to enhance safety when using imiquimod to treat children diagnosed with skin disorders
10/02/2008WO2008118758A1 Inhibitors of ion channels
10/02/2008WO2008118754A2 Gamma radiation sterilized nanoparticulate docetaxel compositions and methods for making the same
10/02/2008WO2008118747A1 Amimomethyl azaadamantane derivatives and use thereof as selective modulators of the alpha7- neuronal nicotinic acetylcholine receptor (nnrs)
10/02/2008WO2008118744A1 Anti-inflammatory compositions comprising tetracyclines and use thereof in therapy
10/02/2008WO2008118724A1 Indole carboxamides as ikk2 inhibitors
10/02/2008WO2008118718A2 2-aminopyridine analogs as glucokinase activators
10/02/2008WO2008118654A1 Improved preparation of oxymorphone from oripavine
10/02/2008WO2008118653A1 Iminopyrrolidone thiol amino acid conjugates, pharmaceutical compositions and methods for the treatment of cancer
10/02/2008WO2008118644A1 Treatment of female sexual dysfunction by compounds that positively modulate ampa-type glutamate receptors
10/02/2008WO2008118552A1 Use of ranolazine for the treatment of cardiovascular diseases
10/02/2008WO2008118485A1 Novel imidazo based heterocycles
10/02/2008WO2008118468A1 Heterocyclic compounds and their uses
10/02/2008WO2008118455A1 δ3- SUBSTITUTED QUINOLINE OR QUINOXALINE DERIVATIVES AND THEIR USE AS PHOSPHATIDYLINOSITOL 3-KINASE ( PI3K) INHIBITORS
10/02/2008WO2008118454A2 Derivatives of quinoline or benzopyrazine and their uses for the treatment of (inter alia) inflammatory diseases, autoimmune diseases or various kinds of cancer
10/02/2008WO2008118426A1 Split dose corticosteroid therapy
10/02/2008WO2008118423A1 Compositions and methods for treating medical conditions
10/02/2008WO2008118414A1 Substituted pyrido[3,2-e][1,2,4]triazolo[4,3-c]pyrimidine derivatives as cannabinoid-1 receptor modulators
10/02/2008WO2008118403A2 Method of using a pkc inhibitor to reverse prefrontal cortical declines
10/02/2008WO2008118327A1 Conformationally restrained epothilone analogues as anti-leukemic agents
10/02/2008WO2008118320A1 Reduction of adverse events.after percutaneous intervention by use of a thrombin receptor antagonist
10/02/2008WO2008118319A2 Mineralocorticoid receptor modulators
10/02/2008WO2008118278A1 Direct application of non-toxic crosslinking reagents to restabilize surgically destabilized intervertebral joints
10/02/2008WO2008118164A1 Compounds to promote regeneration of bone marrow
10/02/2008WO2008118141A2 Use of cannabinoid modulating compounds in combination with other therapeutic compounds for adjunctive therapy
10/02/2008WO2008118092A1 Maleate salt of 3-bromo-n-{ (2s) -2- (4-f luorophenyl) -4- [3- (4-acetylpiperazin-1-yl) azetidin-1-yl] butyl} -methyl-5- (trifluoromethyl)benzamide for the treatment of gastrointestinal disorders
10/02/2008WO2008118091A1 A fumarate salt of 3-bromo-n-{ (2s) -2- (4 -fluorophenyl) -4- [3- (4-acetylpiperazin-l-yl) azetidin-1-yl] butyl} -n-methyl-5- (trifluoromethyl)benzamide for the treatment of gastrointestinal disorders
10/02/2008WO2008118032A1 Compositions for treating intoxications comprising a phξnothiazine compound
10/02/2008WO2008117970A1 Use of inhibitors of leukotriene b4 receptor blt2 for treating human cancers
10/02/2008WO2008117901A1 A method for isolation of high concentration of magnesium lithospermate b from salviae miltiorrhizae
10/02/2008WO2008117862A1 Novel (2-aminophenyl)pyridinecarboxamide derivative having urea structure
10/02/2008WO2008117861A1 Intraocular pressure lowering agents containing phenylenediamine derivatives as the active ingredient
10/02/2008WO2008117828A1 Prompt nucleic acid delivery carrier composition
10/02/2008WO2008117815A1 Inhibitor for cell death caused by endoplasmic reticulum stress or oxidation stress
10/02/2008WO2008117801A1 Composition for cartilage protection
10/02/2008WO2008117796A1 Novel mutilin derivatives
10/02/2008WO2008117790A1 Food/beverage and pharmaceutical composition for oral administration for improvement in acidic urine each comprising fucoidan as active ingredient
10/02/2008WO2008117775A1 Taxanes having oxetane ring structure
10/02/2008WO2008117773A1 Process for production of asymmetric tetrasubstituted quinolonecarboxylic acids and intermediates for the production
10/02/2008WO2008117707A1 Ground crystal of olmesartan medoxomil
10/02/2008WO2008117523A1 Antiviral agent
10/02/2008WO2008117389A1 Drug for treating retinal disorders, utilization of the same and therapeutic method using the same
10/02/2008WO2008117282A1 Polymorph of granisetron base and production process therefor
10/02/2008WO2008117269A2 Heterotri cyciii c compounds as serotonergic and/or dopaminergic agents and uses thereof
10/02/2008WO2008117229A1 Muscarinic receptor antagonists
10/02/2008WO2008117225A2 New imidazolo-heteroaryl derivatives with antibacterial properties
10/02/2008WO2008117169A1 Pyrimido [4, 5-d] azepine derivatives as 5-ht2c agonists
10/02/2008WO2008117154A2 Stable pharmaceutical compositions, preferably tablets, of hmg-coa reductase inhibitor and process for preparation thereof
10/02/2008WO2008117125A2 Compositions capable of facilitating penetration across a biological barrier
10/02/2008WO2008117104A2 Reverse auction system with retractible bids
1 ... 3058 3059 3060 3061 3062 3063 3064 3065 3066 3067 3068 3069 3070 3071 3072 3073 3074 3075 3076 3077 3078 ... 7860